Opera CRO, a TIGERMED Group Company
55
1
1
36
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.8%
1 terminated/withdrawn out of 55 trials
97.3%
+10.8% vs industry average
9%
5 trials in Phase 3/4
0%
0 of 36 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (55)
Osmonar® Nasal Gel Versus Saline Solution in Patients With Dry Nose
Role: collaborator
Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® S in the Correction of Moderate or Severe Infraorbital Hollowing
Role: collaborator
Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® M in Lip Augmentation
Role: collaborator
Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® XL for the Restoration and/or Augmentation of Facial Volume
Role: collaborator
Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.
Role: collaborator
Open-label Trial Evaluating Four Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste, and Mouthwash
Role: collaborator
Study to Evaluate the Performance and Safety of the Medical Device Argogen
Role: collaborator
Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis
Role: collaborator
Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone
Role: collaborator
Performance and Tolerability of the Medical Device LACRIACT
Role: collaborator
Prevalence and Burden of Nausea and Vomiting in Pregnant Women in Switzerland: Survey Purity 2022
Role: collaborator
Tocopherol Acetate Vaginal Administration in Pre-peri and Postmenopausal Women
Role: collaborator
Randomised, Double-blind, Placebo-controlled to Assess the Efficacy and Safety of the Food Supplement Microsmin® Plus
Role: collaborator
Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects
Role: collaborator
Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue Defects
Role: collaborator
Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects
Role: collaborator
Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects
Role: collaborator
To Assess The Performance And Tolerance Of Janesse 20 In The Volume Restoration Of Labia Majora
Role: collaborator
Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of ORTHIX PLUS
Role: collaborator
Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO
Role: collaborator